Delayed passage of anti-rebate bill gets mixed reactions

Published: 2013-06-21 07:00:00

Updated: 2013-06-21 07:00:00

As the National Assembly’s Health and Welfare Committee on Wednesday decided not to push for legislation that will implement tougher anti-violence measures against drug makers during this month’s parliamentary session, the local industry shows mixed reactions to the delay of the anti-rebate bill....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK